| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 18, 2024 4:15 P.M. |
| Form: | S-1 | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | October 18, 2024 4:15 P.M. |
| Form: | S-1 | ||||||
| |||||||
Save time and jump to the most important pieces.
Gainers CNS Pharma (NASDAQ:CNSP) stock rose 109.5% to $2.64 during Thursday's pre-market session. The company's market cap stands at $2.2 million. Autonomix Medical (NASDAQ:AMIX) stock moved upwards by 37.23% to $1.29. The company's market cap stands at $24.3 million. Inspire Veterinary (NASDAQ:IVP) shares moved upwards by 21.37% to $1.59. The company's market cap stands at $1.5 million. Salarius Pharmaceuticals (NASDAQ:SLRX) stock increased by 13.63% to $2.5. The market value of their outstanding shares is at $1.4 million. Absci (NASDAQ:ABSI) stock increased by 13.46% to $3.37. The company's market cap stands at $381.0 million. Traws Pharma (NASDAQ:TRAW) stock increased by 12.32% to $
8-K - DIH HOLDING US, INC. (0001883788) (Filer)
10-Q/A - DIH HOLDING US, INC. (0001883788) (Filer)
10-Q - DIH HOLDING US, INC. (0001883788) (Filer)
NORWELL, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporates visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced financial results for the second fiscal quarter ended September 30, 2024, and a restatement of the financial results for the first fiscal quarter ended June 30, 2024, to account for the timing of revenue and associated cost of sales recognition for two devices sold in lat
NORWELL, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a leading global robotics and virtual reality ("VR") technology provider in the rehabilitation and human performance industry, today announced the appointment of Mr. Dietmar Dold as Chief Operating Officer, effective immediately. Mr. Dold brings to DIH over 25 years of operating experience across multiple industries, and has demonstrated significant expertise in driving innovative transformation on a global scale. In his role as Chief Operating Officer, Mr. Dold will define and lead DIH's multi-group operating strategy, where he is expected to optimize manufacturing and sourcing initiatives, buil
NORWELL, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the formation of its Scientific Advisory Board ("SAB"). The newly formed SAB will advise DIH on technical and scientific pursuits, offer insights into the latest trends in the scientific and clinical communities, provide feedback on product development, and advise DIH on research
3 - DIH HOLDING US, INC. (0001883788) (Issuer)
4 - DIH HOLDING US, INC. (0001883788) (Issuer)
3 - DIH HOLDING US, INC. (0001883788) (Issuer)
SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)
SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)
SC 13D - DIH HOLDING US, INC. (0001883788) (Subject)
NORWELL, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a leading global robotics and virtual reality ("VR") technology provider in the rehabilitation and human performance industry, today announced the appointment of Mr. Dietmar Dold as Chief Operating Officer, effective immediately. Mr. Dold brings to DIH over 25 years of operating experience across multiple industries, and has demonstrated significant expertise in driving innovative transformation on a global scale. In his role as Chief Operating Officer, Mr. Dold will define and lead DIH's multi-group operating strategy, where he is expected to optimize manufacturing and sourcing initiatives, buil
NORWELL, Mass. and HAAPSALU, Estonia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced that Haapsalu Neurological Rehabilitation Center (HNRC), located in Haapsalu, Estonia, has been appointed as the latest DIH Center of Excellence. Recognized for its pioneering work in neurological rehabilitation, Haapsalu Neurological Rehabilitation C
ZURICH, Switzerland, June 25, 2024 (GLOBE NEWSWIRE) -- DIH HOLDING US, Inc. ("DIH") (NASDAQ:DHAI), a leading global robotics and virtual reality ("VR") technology provider in the rehabilitation and human performance industry, today announced that the Zihlschlacht Rehabilitation Clinic, founded in 1891 as a sanatorium, has been appointed as the first DIH Center of Excellence in Switzerland. Located on the Swiss side of Lake Constance, the clinic is renowned for its leadership in treating neurological diseases and its pioneering efforts in neurorehabilitation and research. The DIH Center of Excellence program recognizes strategic partners that showcase best practices in rehabilitation robot